Chelmsford, United Kingdom

Roger John Aitchison Walsh

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger John Aitchison Walsh. Retrieved from https://idiyas.com/inventor/roger-john-aitchison-walsh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roger John Aitchison Walsh: Innovator in Chemical Compounds

Introduction

Roger John Aitchison Walsh is a notable inventor based in Chelmsford, GB. He has made significant contributions to the field of chemical compounds, showcasing his expertise and innovative spirit. His work has led to the development of a patent that reflects his commitment to advancing scientific knowledge.

Latest Patents

Roger John Aitchison Walsh holds a patent concerning chemical compounds. The present invention focuses on compounds of general formula (I), in which the substituents are as described in the patent documentation. This patent highlights his ability to create novel solutions in the chemical domain.

Career Highlights

Roger is currently associated with Aventis Pharma S.A., a company known for its dedication to pharmaceutical innovation. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the development of new chemical compounds.

Collaborations

Throughout his career, Roger has collaborated with talented individuals such as Andrew James Ratcliffe and Tahir Nadeem Majid. These collaborations have likely enriched his work and fostered a creative environment for innovation.

Conclusion

In summary, Roger John Aitchison Walsh is a distinguished inventor whose work in chemical compounds has led to valuable patents. His contributions to Aventis Pharma S.A. and collaborations with other professionals underscore his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…